<?xml version="1.0" encoding="UTF-8"?>
<p>The G190A mutation was also relatively more frequent among subtype C infected patients failing NNRTI-based therapy in Israel and India. In the Israeli but not the Indian study, G190A/S was seen as a natural polymorphism in subtype C from Ethiopian immigrants [
 <xref ref-type="bibr" rid="b25-viruses-02-02493">25</xref>,
 <xref ref-type="bibr" rid="b49-viruses-02-02493">49</xref>]. In both studies, the frequencies of these mutations among treated patients were higher than in subtype B and C drug-na√Øve patients.
</p>
